Genetic Non-Invasive Prenatal Screening Tests May Have False Results: FDA Safety Communication
Pregnant patients should discuss test results with a health care provider before making any decisions about their pregnancy
Italiano
Pregnant patients should discuss test results with a health care provider before making any decisions about their pregnancy
Fri, 15 Apr 2022 10:47:49 -0400
Thu, 14 Apr 2022 11:57:24 -0400
Tue, 12 Apr 2022 12:04:45 -0400
Nucala is indicated as add-on maintenance treatment with intranasal corticosteroids in adult patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) inadequately controlled by intranasal corticosteroids alone.
Tue, 12 Apr 2022 11:32:49 -0400
Mylan Pharmaceuticals Inc., a Viatris company, is voluntarily recalling one batch of its Insulin Glargine (Insulin glargineyfgn) Injection, 100 units/mL (U-100), which is packaged in a 10 mL vial that is inside a carton. This product is not the branded Semglee vial but the unbranded Insulin Glargine
Mon, 11 Apr 2022 13:39:53 -0400
Oxlumo (lumasiran) is indicated for the treatment of primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in pediatric and adult patients.
Mon, 11 Apr 2022 09:50:26 -0400
The U.S. Food and Drug Administration (FDA) wants to increase awareness about the intended use of imaging software for intracranial large vessel occlusion or LVO.
80.211.154.110